2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Sharad Ghamande, MD

Professor
Georgia Regents University
1120 15th Street, BA-7411
Augusta, GA
USA 30912

Papers:
8 A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)